GlassScriptPhysician profile
Kelly L Hamblin
NPI 1770515926
$12,506.02
in general payments reported to CMS, 2019-2025
26 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,870 · 2020: $343 · 2021: $4,063 · 2022: $26.79 · 2023: $464 · 2024: $2,548 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664 · Travel and Lodging: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.60 |
| Travel and Lodging | $1,540.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,662.87 | 2019-2024 | |
| Wright Medical Technology, INC. | $2,301.74 | 2019 | |
| Active Medical, LLC | $1,576.67 | 2019-2024 | |
| Paragon 28, INC. | $1,228.16 | 2024 | Hammertube Sterile Implant Kits, Portfolio, Paratrooper |
| Stryker Corporation | $439.70 | 2019-2025 | Prostep, Prostep Mica |
| Accufix Surgical INC. | $422.59 | 2023 | Accu-Joint |
| Novo Nordisk INC | $128.58 | 2019-2021 | |
| Zyla Life Sciences, INC. | $123.25 | 2019-2020 | |
| Orthofix Medical, INC. | $98.89 | 2023-2025 | Physio-Stim |
| Pfizer INC. | $68.22 | 2019-2021 | |
| Mimedx Group, INC. | $64.71 | 2024-2025 | |
| Lilly USA, LLC | $55.56 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.96 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $41.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $41.50 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $26.98 | 2021 | |
| Tactile Systems Technology INC | $26.31 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Abbvie INC. | $24.38 | 2021 | |
| Biocomposites INC | $24.04 | 2024 | |
| Edwards Lifesciences Corporation | $23.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.29 | 2022 | |
| Glaxosmithkline, LLC. | $14.03 | 2025 | Bexsero, Arexvy, Shingrix |
| Celularity INC. | $14.00 | 2019 | |
| Cranial Technologies, INC | $13.54 | 2019 | |
| Integra Lifesciences Corporation | $13.41 | 2020 | |
| Aroa Biosurgery Incorporated | $9.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Hamblin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.